[et_pb_section fb_built=”1″ _builder_version=”4.11.2″ _module_preset=”default” use_background_color_gradient=”on” background_color_gradient_start=”#c43779″ background_color_gradient_end=”#c4b8be” background_color_gradient_type=”radial” background_color_gradient_direction_radial=”top left” background_image=”https:\/\/guildconference.com\/2022\/wp-content\/uploads\/2021\/09\/purple-background.jpg” custom_padding=”0px||50px||false|false” box_shadow_style=”preset1″ global_colors_info=”{}”][et_pb_row _builder_version=”4.11.2″ _module_preset=”default” background_color=”#FFFFFF” custom_padding=”|25px||25px|false|true” border_width_right=”1px” border_color_right=”#b7b7b7″ border_width_bottom=”1px” border_color_bottom=”#b7b7b7″ border_width_left=”1px” border_color_left=”#b7b7b7″ global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.10.8″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.11.2″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
\nConference Resources 2020<\/h2>\n<\/blockquote>\n
Materials for GUILD 2020 symposia are available for attendees of the live conferences as password protected<\/strong> pdf files. Please note, this encryption may lead to delays if you are trying to open the slides on a mobile device such as an iPad or smart phone or if you attempt to view the slides in your browser.<\/p>\n
For best results, download the presentations to your computer by right-clicking on the \u201cdownload\u201d link and selecting \u201cSave target as\u2026.\u201d (IE), \u201cSave link as\u2026\u201d (Chrome\/Firefox) or \u201cDownload linked file as\u2026\u201d (Safari). You can then open the PDF with an application such as Acrobat Reader<\/a>.<\/p>\n
Please note that reproduction, recreation or other unauthorized use of this content is prohibited.<\/p>\n
\n
- ACOSTA: Obesity Epidemic<\/a><\/li>\n
- ACOSTA: Obesity Therapy<\/a><\/li>\n
- CHANG: TBS<\/a><\/li>\n
- CHEIFETZ: Crohns<\/a><\/li>\n
- CHEIFETZ: IBD Treatment<\/a><\/li>\n
- GARCIA-TSAO: Cirrhosis<\/a><\/li>\n
- GARCIA-TSAO: HHT<\/a><\/li>\n
- HA: IBD-Diagnosis Prognosi<\/a><\/li>\n
- HA: IBD-Older Patient<\/a><\/li>\n
- KAVANAUGH: IBD-Older Patient<\/a><\/li>\n
- KOWDLEY: NASH<\/a><\/li>\n
- KOWDLEY: PSC-New Therapies<\/a><\/li>\n
- KULIK: Liver Mass<\/a><\/li>\n
- LOFTUS: JAK-Inhibitors<\/a><\/li>\n
- LOFTUS-REGUEIRO: Crohns Year In Review<\/a><\/li>\n
- LONG: IBD-Infection<\/a><\/li>\n
- LONG: IBD-Maintenance<\/a><\/li>\n
- MAHADEVAN: IL23<\/a><\/li>\n
- MARTIN: Dermatology<\/a><\/li>\n
- REGUEIRO: Crohns Management<\/a><\/li>\n
- RUBIN: Diagnostic Dilemmas<\/a><\/li>\n
- RUBIN: Social Media<\/a><\/li>\n
- RUBIN-VELAYOS: Ulcerative Colitis<\/a><\/li>\n
- TERRAULT: Alcohol Associated Hepatitis<\/a><\/li>\n
- TERRAULT: Viral Hepatitis Update<\/a><\/li>\n
- VELAYOS: Ulcerativ Colitis Boot Camp<\/a><\/li>\n
- VELAYOS: Ulcerativ Colitis Boot Camp Cases<\/a><\/li>\n<\/ul>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Questions Section” _builder_version=”4.10.8″ _module_preset=”default” custom_padding=”15px||15px||true|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.10.8″ _module_preset=”default” custom_padding=”0px||0px||true|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.10.8″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.11.3″ _module_preset=”default” custom_padding=”0px||0px||true|false” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n
\nQuestions?<\/h4>\n